Condition
Alzheimer Disease 2
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown1
Withdrawn1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05637801Not ApplicableActive Not Recruiting
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
NCT04100889Withdrawn
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
NCT03806478Phase 2Unknown
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
Showing all 3 trials